Induction of an inhibitor antibody to factor XI in a patient with severe inherited factor XI deficiency by Rh immune globulin

Blood

Volumn 111, Issue 3, 2008, Pages 1306-1308

  Zucker, Michal ^a   Zivelin, Ariella ^a   Teitel, Jerome ^b   Seligsohn, Uri ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11; CALCIUM CHLORIDE; DNA; GLUTAMIC ACID; IMMUNOGLOBULIN G; PROTEIN A; PROTEIN INHIBITOR; RHESUS D ANTIBODY;

ADULT; ANAMNESIS; ARTICLE; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CASE REPORT; CHEMOLUMINESCENCE; DISEASE SEVERITY; DNA EXTRACTION; DOMINANT INHERITANCE; DRUG BLOOD LEVEL; FEMALE; GENE MUTATION; GESTATION PERIOD; HOMOZYGOSITY; HUMAN; LABORATORY TEST; MENSTRUATION DISORDER; PREGNANCY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PURIFICATION; WESTERN BLOTTING;

EID: 38949129768     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-08-108449     Document Type: Article

References (10)

1. Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med. 1991;325:153-158.
2. Salomon O, Zivelin A, Livnat T, et al. Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency. Blood. 2003;101:4783-4788.
3. Shpilberg O, Peretz H, Zivelin A, et al. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (Type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood. 1995;85:429-432.
4. Zadra G, Asselta R, Malcovati M, et al. Molecular genetic analysis of severe coagulation factor XI deficiency in six Italian patients. Haematologica. 2004;89:1332-1340.
5. Bouma BN, Griffin JH. Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII. J Biol Chem. 1977;252:6432-6437.
6. Alving BM, Tankersley DL, Mason BL, Rossi F, Aronson DL, Finlayson JS. Contact-activated factors: Contaminants of immunoglobulins preparations with coagulant and vasoactive properties. J Lab Clin Med. 1980;96:334-346.
7. Wolberg AS, Kon RH, Monroe DM, Hoffman M. Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations. Am J Hematol. 2000;65:30-34.
8. Peretz H, Mulai A, Usher S, et al. The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin. Blood. 1997;90:2654-2659.
9. Zivelin A, Bauduer F, Ducout L, et al. Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood. 2002;99:2448-2454.
10. Bolton-Maggs PH, Peretz H, Butler R, et al. A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency. J Thromb Haemost. 2004;2:918-924.